ImmunoCAP Rapid
Fast Answers for Fast Action
These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.
Specific IgE Point-of-Care
ImmunoCAP™ Rapid™ is a quick and user-friendly point-of-care test to be performed in near-patient healthcare settings such as doctors’ offices and nurse stations to rule in or rule out allergy.1,2 It identifies 92 to 95 percent of symptomatic patients sensitized to any of the included allergens.3,4
There are three different test panels available, each holding a fixed set of 10 different allergens.*
| ImmunoCAP Rapid Wheeze/Rhinitis Child |
|---|
Cat Birch Mugwort Timothy Egg White Dog Olive pollen Wall pellitory House dust mite Cow's milk |
| ImmunoCAP Rapid Wheeze/Rhinitis Child |
|---|
| ImmunoCAP Rapid Asthma/Rhinitis Adult |
|---|
Cat Birch Mugwort Timothy Cockroach Dog Olive Wall pellitory House dust mite Mold |
| ImmunoCAP Rapid Asthma/Rhinitis Adult |
|---|
| ImmunoCAP Rapid Rhinitis/Asthma 1* |
|---|
Cat Mold Cocksfoot Common ragweed Mugwort Dog Cockroach Japanese Cedar
|
| ImmunoCAP Rapid Rhinitis/Asthma 1* |
|---|
*ImmunoCAP Rapid Rhinitis/Asthma 1 holds eight different allergens.
Single-use technology
ImmunoCAP Rapid is a single use, disposable testing device.
Broad application
The ImmunoCAP Rapid test can be performed irrespective of age, symptoms, disease activity, and antihistamine medication.
Easy and quick testing
ImmunoCAP Rapid is a specific IgE antibody blood test that will determine whether antibodies to any of the allergens included in the test are present in your patient’s blood. The test will provide a clear and reliable answer in 20 minutes while you wait.
Reliable results
You will receive proven and reliable results, with good concordance to ImmunoCAP Specific IgE blood tests.5
ImmunoCAP Rapid is available in dedicated European countries and in Japan.
Quickly rule in or rule out allergy
The test is a first-line evaluation tool that supports healthcare providers in the decision to rule in or rule out allergy.1,2
The test results should be interpreted in the context of the patient’s clinical history, before making a diagnosis. Regardless of the results, it is recommended that a symptomatic patient follow up with their healthcare provider.
- Sarratud, T., et al., Accuracy of a point-of-care testing device in children with suspected respiratory allergy. Allergy Asthma Proc, 2010. 31(2): p. e11-7.
- Diaz-Vazquez, C., et al., Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study. Pediatr Allergy Immunol, 2009. 20(6): p. 601-9.
- Hedlin, G., et al., Allergy Diagnosis in Children and Adults: Performance of a New Point-of-Care Device, ImmunoCAP Rapid. World Allergy Organ J, 2009. 2(7): p. 138-43.
- Eigenmann, P.A., et al., The ImmunoCAP Rapid Wheeze/Rhinitis Child test is useful in the initial allergy diagnosis of children with respiratory symptoms. Pediatr Allergy Immunol, 2009. 20(8): p. 772-9.
- Jan Forslid, P.M.L.S., Laboratory evaluation of a qualitative in vitro test for specific IgE in primary care as compared to quantitative measurement using automated ImmunoCAP FEIA processing. EAACI, 2008. Poster discussion 230.
